US equities
|
SPCX
$147.79
▲+0.00%
MU
$896.07
▲+0.00%
TSLA
$373.71
▲+0.00%
NVDA
$216.47
▲+0.00%
SNDK
$1,365.38
▲+0.00%
SKHY
$139.79
▲+0.00%
INTC
$91.69
▲+0.00%
AMD
$534.74
▲+0.00%
SPCX
$147.79
▲+0.00%
MU
$896.07
▲+0.00%
TSLA
$373.71
▲+0.00%
NVDA
$216.47
▲+0.00%
SNDK
$1,365.38
▲+0.00%
SKHY
$139.79
▲+0.00%
INTC
$91.69
▲+0.00%
AMD
$534.74
▲+0.00%
FinancialContent
Sign in
Markets
Overview
News
World markets
Treasuries
Currencies
Commodities
Economy
Stocks
Overview
Most active
Gainers
Losers
Largest companies
52-week gainers
52-week losers
ETFs
Overview
Popular funds
Most active
Gainers
Losers
News
Research
Search
Sectors
Tools
My watchlist
My portfolio
Recent quotes
Nutriband Inc. - Common Stock
(NQ:
NTRB
)
5.850
UNCHANGED
Delayed Quote
Updated: 4:00 PM EDT, Oct 20, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Nutriband Inc. - Common Stock
< Previous
1
2
3
4
5
6
7
8
9
...
12
13
Next >
Nutriband Inc. Quarterly Report Highlights Record Revenue for Q2, 2025 up 50.87% YOY and Strategic Progress Toward NDA Filing for AVERSA Fentanyl
September 10, 2025
From
Nutriband Inc.
Via
GlobeNewswire
InvestorNewsBreaks – Nutriband Inc. (NASDAQ: NTRB) Scales Manufacturing, Eyes Global Commercialization of AVERSA(TM)
September 09, 2025
Via
Investor Brand Network
Topics
Intellectual Property
Nutriband Inc. (NASDAQ: NTRB) CEO Showcases AVERSA(TM) Abuse Deterrent Transdermal Technology at Emerging Growth Conference
September 08, 2025
Via
Investor Brand Network
Topics
Initial Public Offering
BioMedNewsBreaks – Nutriband Inc. (NASDAQ: NTRB) Secures $5.3 Million from Warrant Exercises to Advance AVERSA Fentanyl NDA
September 04, 2025
Via
Investor Brand Network
Nutriband Inc. announces exercise of warrants at $6.43 for Gross Proceeds of $5,306,000
September 03, 2025
From
Nutriband Inc.
Via
GlobeNewswire
Nutriband Inc. (NASDAQ: NTRB): When Regulatory Momentum Meets Leadership Continuity
August 20, 2025
Via
Investor Brand Network
BioMedNewsBreaks – Nutriband Inc. (NASDAQ: NTRB) to Present at Emerging Growth Conference on August 20
August 18, 2025
Via
Investor Brand Network
Nutriband Inc. to Present on the Emerging Growth Conference on August 20, 2025
August 18, 2025
Nutriband Inc. invites individual and institutional investors as well as advisors and analysts, to attend its real-time, interactive presentation on the Emerging Growth Conference
From
Nutriband Inc.
Via
GlobeNewswire
InvestorNewsBreaks – Nutriband Inc. (NASDAQ: NTRB) CEO Steps Aside Temporarily to Run for Irish Presidency
August 11, 2025
Via
Investor Brand Network
Topics
Intellectual Property
Nutriband CEO Gareth Sheridan Seeks Nomination in Upcoming Irish Presidential Election
August 11, 2025
From
Nutriband Inc.
Via
GlobeNewswire
BioMedNewsBreaks – Nutriband Inc. (NASDAQ: NTRB) Secures FDA Type C Meeting for AVERSA(TM) Fentanyl Abuse-Deterrent Patch
August 08, 2025
Via
Investor Brand Network
Topics
Intellectual Property
12 Health Care Stocks Moving In Friday's Pre-Market Session
↗
August 08, 2025
Via
Benzinga
FDA Grants Nutriband Meeting Request for Aversa™ Fentanyl Abuse Deterrent Fentanyl Patch
August 08, 2025
From
Nutriband Inc.
Via
GlobeNewswire
Nutriband Inc. (NASDAQ: NTRB) Navigates Drug-Delivery Challenges with Innovation in Abuse-Deterrent Tech
August 06, 2025
Via
Investor Brand Network
Nutriband Inc. (NASDAQ: NTRB) Aligns Shareholder Value with FDA Milestone
August 05, 2025
Via
Investor Brand Network
BioMedNewsBreaks — Nutriband Inc. (NASDAQ: NTRB): Innovation Meets Science Through Scalable Platform
July 25, 2025
Via
Investor Brand Network
Topics
Intellectual Property
BioMedNewsBreaks – Nutriband Inc. (NASDAQ: NTRB) Sets Key Dates for 25% Preferred Stock Dividend
July 18, 2025
Via
Investor Brand Network
Nutriband Confirms Record and Pay date for 25% Preferred Stock Dividend as it Targets Filing for FDA Approval
July 18, 2025
From
Nutriband Inc.
Via
GlobeNewswire
InvestorNewsBreaks – Rare Biotech Story: Nutriband Inc. (NASDAQ: NTRB) Founder Shares Vision in Smart Money Circle Podcast
July 11, 2025
Via
Investor Brand Network
Nutriband Inc. (NASDAQ: NTRB) Added to Four Key Indexes, Rethinking Opioid Safety in a Time of Crisis
July 03, 2025
Via
Investor Brand Network
Topics
Intellectual Property
12 Health Care Stocks Moving In Wednesday's Intraday Session
↗
July 02, 2025
Via
Benzinga
InvestorNewsBreaks – Nutriband Inc. (NASDAQ: NTRB) Declares 25% Preferred Stock Dividend Linked to AVERSA Fentanyl Approval
July 02, 2025
Via
Investor Brand Network
Nutriband Announces 25% Preferred Stock Dividend as it targets filing for FDA approval
July 02, 2025
From
Nutriband Inc.
Via
GlobeNewswire
Investing in Innovation: Four Small-Caps Driving the Future of Pain Therapy (NTRB, COLL, ASRT, AQST)
July 02, 2025
Via
AB Newswire
Investing in Innovation: Four Small-Caps Driving the Future of Pain Therapy
July 02, 2025
Investing in Innovation: Four Small-Caps Driving the Future of Pain Therapy
Via
News Direct
BioMedNewsBreaks – Nutriband Inc. (NASDAQ: NTRB) Added to Four Russell Indexes in 2025 Reconstitution
July 01, 2025
Via
Investor Brand Network
Nutriband Inc. added to the Russell Microcap® Index, Russell Microcap Growth® Index, Russell 3000E® Index and Russell 3000E Growth® Index
July 01, 2025
From
Nutriband Inc.
Via
GlobeNewswire
BioMedNewsBreaks – Nutriband Inc. (NASDAQ: NTRB) Price Target Raised to $15 Following AVERSA Fentanyl Manufacturing Milestone
June 23, 2025
Via
Investor Brand Network
Nutriband Inc. (NASDAQ: NTRB) Reimagining Drug Safety Through Scalable Innovation
June 20, 2025
Via
Investor Brand Network
Topics
Death
Intellectual Property
BioMedNewsBreaks – Nutriband Inc. (NASDAQ: NTRB) Advances Aversa Fentanyl with Kindeva to Commercial Manufacturing Scale
June 18, 2025
Via
Investor Brand Network
Topics
Intellectual Property
< Previous
1
2
3
4
5
6
7
8
9
...
12
13
Next >
